These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16563665)

  • 1. A nucleotide mutation associated with fluoroquinolone resistance observed in gyrA of in vitro obtained Rhodococcus equi mutants.
    Niwa H; Hobo S; Anzai T
    Vet Microbiol; 2006 Jun; 115(1-3):264-8. PubMed ID: 16563665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA.
    Turkmani A; Psaroulaki A; Christidou A; Chochlakis D; Tabaa D; Tselentis Y
    Int J Antimicrob Agents; 2008 Sep; 32(3):227-32. PubMed ID: 18583100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis.
    Peterson ML; Rotschafer JC; Piddock LJ
    J Antimicrob Chemother; 2003 Sep; 52(3):481-4. PubMed ID: 12917248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
    Pasquali F; Rossi M; Manfreda G; Zanoni R
    Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
    Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
    Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A.
    Vashist J; Vishvanath ; Kapoor R; Kapil A; Yennamalli R; Subbarao N; Rajeswari MR
    Indian J Biochem Biophys; 2009 Apr; 46(2):147-53. PubMed ID: 19517991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA.
    Angelakis E; Biswas S; Taylor C; Raoult D; Rolain JM
    J Antimicrob Chemother; 2008 Jun; 61(6):1252-5. PubMed ID: 18334491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand.
    Pitaksajjakul P; Wongwit W; Punprasit W; Eampokalap B; Peacock S; Ramasoota P
    Southeast Asian J Trop Med Public Health; 2005; 36 Suppl 4():228-37. PubMed ID: 16438215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
    McIver C; Hogan T; White P; Tapsall J
    Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
    Preisler A; Heisig P
    J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
    Beckmann L; Müller M; Luber P; Schrader C; Bartelt E; Klein G
    J Appl Microbiol; 2004; 96(5):1040-7. PubMed ID: 15078520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
    Beeton ML; Chalker VJ; Kotecha S; Spiller OB
    J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
    Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.
    Rimbara E; Noguchi N; Kawai T; Sasatsu M
    Helicobacter; 2012 Feb; 17(1):36-42. PubMed ID: 22221614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
    Lázaro FG; Rodríguez-Tarazona RE; García-Rodríguez JA; Muñoz-Bellido JL
    Int J Antimicrob Agents; 2009 Sep; 34(3):252-4. PubMed ID: 19243922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance.
    Hirose K; Kawasaki Y; Kotani K; Abiko K; Sato H
    J Vet Med B Infect Dis Vet Public Health; 2004 May; 51(4):169-75. PubMed ID: 15228551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
    Billal DS; Fedorko DP; Yan SS; Hotomi M; Fujihara K; Nelson N; Yamanaka N
    J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure.
    Yan M; Sahin O; Lin J; Zhang Q
    J Antimicrob Chemother; 2006 Dec; 58(6):1154-9. PubMed ID: 17023497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.